Table 2.

List of ongoing clinical trials comparing TIVA to volatile aneasthesia

Trial identifier	Cancer type	Estimated enrollment	Study arms	Outcomes	Trial status and estimated completion date
NCT03193710	Colorectal cancer	260	Propofol vs Sevoflurane	Cancer free survival, Recurrence, metastasis up to 5 years	Recruiting, October 2023
NCT03034096	All cancer surgery	2000	Propofol vs volatiles	Mortality, recurrence free survival at least 2 years	Recruiting, December 2020
NCT02839668	Breast cancer	120	Propofol vs sevoflurane; +/- Lidocaine	Survival up to 1 year	Ongoing, December 2018
NCT02786329	Colorectal cancer	450	Propofol vs sevoflurane	Recurrence up to 5 years	Recruiting, December 2021
NCT02756312	Malignant Glioma	500	Propofol vs volatiles	Progression free survival up to 1 year	Ongoing, December 2018
NCT01975064	Breast, colorectal cancer	8000	Propofol vs sevoflurane	Survival after 5 years	Recruiting, December 2022
NCT02660411	All cancer surgery	1200	Propofol vs sevoflurane	Survival and recurrence free survival up to 3 years	Ongoing, December 2020